ArticleBiomedicines2021

Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.

Zhengli Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.